Breaking News, Trials & Filings

Trials & Filings in Brief: Nov. 4, 2013

ADMA, Allegro, Biothera, Merck, Sagent, Silvergate, UCB

By: Gil Roth

President, Pharma & Biopharma Outsourcing Association

Phase II Allegro begins vitreomacular traction trial . . . read more Biothera NSCLC treatment hits primary endpoint . . . read more Phase III ADMA Bio completes enrollment for PIDD trial . . . read more Merck HPV vax improves on Gardasil . . . read more Filings USB submits Vimpat sNDA . . . read more Launches Sagent launches Carboplatin Injection . . . read more Silvergate launches Epaned for hypertension . . . read more...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters